451 related articles for article (PubMed ID: 12144811)
1. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U
J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
[TBL] [Abstract][Full Text] [Related]
2. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
Nakatani C; Muramatsu T; Shirai T
Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
[TBL] [Abstract][Full Text] [Related]
4. Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
Kromminga A; Sitaru C; Meyer J; Arndt R; Schmidt E; Christophers E; Bröcker EB; Zillikens D
J Dermatol Sci; 2002 Jan; 28(1):68-75. PubMed ID: 11916132
[TBL] [Abstract][Full Text] [Related]
5. Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230.
Leverkus M; Bhol K; Hirako Y; Pas H; Sitaru C; Baier G; Bröcker EB; Jonkman MF; Ahmed AR; Zillikens D
Br J Dermatol; 2001 Dec; 145(6):998-1004. PubMed ID: 11899157
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
[TBL] [Abstract][Full Text] [Related]
7. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida.
Bédane C; McMillan JR; Balding SD; Bernard P; Prost C; Bonnetblanc JM; Diaz LA; Eady RA; Giudice GJ
J Invest Dermatol; 1997 Jun; 108(6):901-7. PubMed ID: 9182819
[TBL] [Abstract][Full Text] [Related]
8. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
Zillikens D
Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
[TBL] [Abstract][Full Text] [Related]
9. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
[TBL] [Abstract][Full Text] [Related]
10. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
Chimanovitch I; Hamm H; Georgi M; Kroiss M; Stolz W; Apitz C; Bröcker EB; Zillikens D
Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
[TBL] [Abstract][Full Text] [Related]
11. Trehalose conserves expression of bullous pemphigoid antigen 180 during desiccation and freezing.
Schmidt E; Kromminga A; Kürschner M; Zimmermann H; Katsen AD; Bröcker EB; Zillikens D; Zimmermann U; Sukhorukov VL
J Immunol Methods; 2003 Apr; 275(1-2):179-90. PubMed ID: 12667682
[TBL] [Abstract][Full Text] [Related]
12. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis.
Giudice GJ; Wilske KC; Anhalt GJ; Fairley JA; Taylor AF; Emery DJ; Hoffman RG; Diaz LA
J Invest Dermatol; 1994 Jun; 102(6):878-81. PubMed ID: 7516396
[TBL] [Abstract][Full Text] [Related]
13. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
[TBL] [Abstract][Full Text] [Related]
14. [New aspects on the pathogenesis of bullous pemphigoid].
Schmidt E; Bröcker EB; Zillikens D
Hautarzt; 2000 Sep; 51(9):637-45. PubMed ID: 11057389
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F
Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641
[TBL] [Abstract][Full Text] [Related]
16. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
Zillikens D; Mascaro JM; Rose PA; Liu Z; Ewing SM; Caux F; Hoffmann RG; Diaz LA; Giudice GJ
J Invest Dermatol; 1997 Nov; 109(5):679-83. PubMed ID: 9347799
[TBL] [Abstract][Full Text] [Related]
17. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
Mai Y; Nishie W; Izumi K; Shimizu H
Front Immunol; 2019; 10():1224. PubMed ID: 31191560
[TBL] [Abstract][Full Text] [Related]
18. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.
Liu Z; Diaz LA; Troy JL; Taylor AF; Emery DJ; Fairley JA; Giudice GJ
J Clin Invest; 1993 Nov; 92(5):2480-8. PubMed ID: 7693763
[TBL] [Abstract][Full Text] [Related]
19. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
[TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]